Clinical Trial Results:
A Double-Blind, Randomized, Parallel, Two-Arm Phase II Trial of BMS-690514 versus Erlotinib in Previously Chemotherapy Treated Non-Small Cell Lung Cancer Patients
Estudio Fase II doble ciego, aleatorizado, de grupos paralelos, de BMS-690514 frente a erlotinib en pacientes con cáncer de pulmón no microcítico previamente tratados con quimioterapia.
Revised Protocol Number 01, incorporating amendment 03
+ Pharmacogenetics Blood Sample Amendment 01 (version 1.0 dated 30-Jul-08)
+ Protocol Amendment 02 FDG-PET Sub-Study (version 1.0 dated 19-Sep-08)
Summary
|
|
EudraCT number |
2008-004691-44 |
Trial protocol |
ES FR |
Global completion date |
07 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA187-017_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.